We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$43.1B
AUM Growth
+$1.45B
(+3.5%)
Cap. Flow
-$96.7M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
45.82%
Holding
319
New
11
Increased
71
Reduced
116
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$194M |
| 2 |
NVIDIA
NVDA
|
+$146M |
| 3 |
UnitedHealth
UNH
|
+$137M |
| 4 |
Meta Platforms (Facebook)
META
|
+$117M |
| 5 |
Philip Morris
PM
|
+$68.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$184M |
| 2 |
HES
Hess
HES
|
+$175M |
| 3 |
Nike
NKE
|
+$95.7M |
| 4 |
PepsiCo
PEP
|
+$94.4M |
| 5 |
Apple
AAPL
|
+$83.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.75% |
| 2 | Financials | 18.34% |
| 3 | Consumer Staples | 10.86% |
| 4 | Healthcare | 8.86% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
O'Reilly Automotive
ORLY
$70.6B
| $823K | ﹤0.01% |
7,635
+105
| +1% | +$10.6K |
|
202
Edwards Lifesciences
EW
$49.3B
| $815K | ﹤0.01% |
10,477
| – | – |
|
203
Corning
GLW
$124B
| $789K | ﹤0.01% |
9,613
+113
| +1% | +$7.38K |
|
204
TJX Companies
TJX
$139B
| $787K | ﹤0.01% |
5,444
+189
| +4% | +$25.1K |
|
205
Unilever
UL
$137B
| $785K | ﹤0.01% |
11,766
| – | – |
|
206
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $746K | ﹤0.01% |
12,444
| – | – |
|
207
Interactive Brokers
IBKR
$41.1B
| $739K | ﹤0.01% |
10,736
+341
| +3% | +$21.5K |
|
208
Fox Class A
FOXA
$27.7B
| $680K | ﹤0.01% |
10,781
-4,000
| -27% | -$231K |
|
209
Ecolab
ECL
$77.2B
| $652K | ﹤0.01% |
2,382
| – | – |
|
|
CYBR
210
DELISTED
CyberArk
CYBR
| $651K | ﹤0.01% |
1,348
| – | – |
|
211
Salesforce
CRM
$214B
| $647K | ﹤0.01% |
2,731
+25
| +0.9% | +$6.3K |
|
|
GRMN
212
Garmin
GRMN
$54.5B
| $647K | ﹤0.01% |
2,627
| – | – |
|
213
General Mills
GIS
$19.5B
| $641K | ﹤0.01% |
12,715
| – | – |
|
214
W.W. Grainger
GWW
$60.3B
| $625K | ﹤0.01% |
656
| – | – |
|
215
Cullen/Frost Bankers
CFR
$10.1B
| $614K | ﹤0.01% |
4,842
-25
| -0.5% | -$3.25K |
|
216
Motorola Solutions
MSI
$77.1B
| $613K | ﹤0.01% |
1,341
| – | – |
|
217
Marvell Technology
MRVL
$197B
| $606K | ﹤0.01% |
7,211
| – | – |
|
218
Plains GP Holdings
PAGP
$5.54B
| $606K | ﹤0.01% |
33,213
| – | – |
|
219
Arista Networks
ANET
$237B
| $585K | ﹤0.01% |
4,014
-14
| -0.3% | -$1.8K |
|
220
GE HealthCare
GEHC
$29B
| $575K | ﹤0.01% |
7,650
-250
| -3% | -$18.6K |
|
221
Paychex
PAYX
$42.2B
| $573K | ﹤0.01% |
4,523
-359
| -7% | -$49.8K |
|
222
Moody's
MCO
$82.3B
| $572K | ﹤0.01% |
1,200
| – | – |
|
223
SEI Investments
SEIC
$12.7B
| $566K | ﹤0.01% |
6,675
| – | – |
|
224
Qualcomm
QCOM
$192B
| $566K | ﹤0.01% |
3,400
-550
| -14% | -$87.2K |
|
225
Eagle Materials
EXP
$5.68B
| $565K | ﹤0.01% |
2,425
| – | – |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q3 2025 Portfolio in Review
As of Q3 2025, Fayez Sarofim & Co held 319 positions worth $43.1B, up 3.5% from $41.7B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Fayez Sarofim & Co's Q3 2025 filing shows 11 new, 71 increased, 116 reduced and 14 closed positions. Its largest new stake was SAP: 49,674 shares worth $13.3M. The largest sale was Novo Nordisk, an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q3 2025 buy was SAP: 49,674 shares worth $13.3M.
- Fayez Sarofim & Co added most to Chevron in Q3 2025, an estimated $194M increase.
- Fayez Sarofim & Co's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $184M.
- Fayez Sarofim & Co fully exited Hess in Q3 2025, selling an estimated $175M.
- Fayez Sarofim & Co's ten largest holdings make up 46% of its $43.1B portfolio in Q3 2025.
- Fayez Sarofim & Co opened 11 new positions and closed 14 in Q3 2025.
- Fayez Sarofim & Co's portfolio value rose 3.5% quarter-over-quarter to $43.1B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2025, filed 14 Nov 2025.